These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics. Baud O; Lehert P; Pediatr Res; 2024 Jan; 95(1):251-256. PubMed ID: 37653218 [TBL] [Abstract][Full Text] [Related]
45. Dose-Response Effects of Early Vitamin D Supplementation on Neurodevelopmental and Respiratory Outcomes of Extremely Preterm Infants at 2 Years of Age: A Randomized Trial. Salas AA; Woodfin T; Phillips V; Peralta-Carcelen M; Carlo WA; Ambalavanan N Neonatology; 2018; 113(3):256-262. PubMed ID: 29393233 [TBL] [Abstract][Full Text] [Related]
46. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial. Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130 [TBL] [Abstract][Full Text] [Related]
47. Early, low-dose hydrocortisone and near-term brain connectivity in extremely preterm infants. Dubner SE; Rickerich L; Bruckert L; Poblaciones RV; Sproul D; Scala M; Feldman HM; Travis KE Pediatr Res; 2024 Mar; 95(4):1028-1034. PubMed ID: 38030826 [TBL] [Abstract][Full Text] [Related]
49. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. Harmon HM; Jensen EA; Tan S; Chaudhary AS; Slaughter JL; Bell EF; Wyckoff MH; Hensman AM; Sokol GM; DeMauro SB; J Perinatol; 2020 Apr; 40(4):616-627. PubMed ID: 32020038 [TBL] [Abstract][Full Text] [Related]
50. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Meyer S; Gortner L; Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948 [TBL] [Abstract][Full Text] [Related]
51. The quality of general movements after treatment with low-dose dexamethasone in preterm infants at risk of bronchopulmonary dysplasia. Hitzert MM; Roescher AM; Bos AF Neonatology; 2014; 106(3):222-8. PubMed ID: 25012880 [TBL] [Abstract][Full Text] [Related]
52. Effects of postnatal hydrocortisone on cytokine profile in extremely preterm infants. Tamura K; Nagaoka M; Inomata S; Kawasaki Y; Makimoto M; Yoshida T Pediatr Int; 2022 Jan; 64(1):e15205. PubMed ID: 35831259 [TBL] [Abstract][Full Text] [Related]
53. A randomized, placebo-controlled GH trial in very preterm infants who were at risk for bronchopulmonary dysplasia and were treated with dexamethasone. Huysman MW; Hop WC; Cromme-Dijkhuis AH; Sauer PJ; Hokken-Koelega AC Pediatr Res; 2005 Oct; 58(4):705-12. PubMed ID: 16189197 [TBL] [Abstract][Full Text] [Related]
54. Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes. Parikh NA; Kennedy KA; Lasky RE; McDavid GE; Tyson JE J Pediatr; 2013 Apr; 162(4):685-690.e1. PubMed ID: 23140612 [TBL] [Abstract][Full Text] [Related]
55. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia. Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722 [TBL] [Abstract][Full Text] [Related]
56. Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT. Dorling J; Hewer O; Hurd M; Bari V; Bosiak B; Bowler U; King A; Linsell L; Murray D; Omar O; Partlett C; Rounding C; Townend J; Abbott J; Berrington J; Boyle E; Embleton N; Johnson S; Leaf A; McCormick K; McGuire W; Patel M; Roberts T; Stenson B; Tahir W; Monahan M; Richards J; Rankin J; Juszczak E Health Technol Assess; 2020 Apr; 24(18):1-94. PubMed ID: 32342857 [TBL] [Abstract][Full Text] [Related]
57. Postnatal oral hydrocortisone in treatment of bronchopulmonary dysplasia: an observational study. Mutlu B; Sandal G; Kanmaz G; Eraslan Z; Erdeve Ö; Oğuz ŞS; Dilmen U Tuberk Toraks; 2013; 61(3):245-9. PubMed ID: 24298974 [TBL] [Abstract][Full Text] [Related]
58. Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia. Bassler D; Shinwell ES; Hallman M; Jarreau PH; Plavka R; Carnielli V; Meisner C; Engel C; Koch A; Kreutzer K; van den Anker JN; Schwab M; Halliday HL; Poets CF; N Engl J Med; 2018 Jan; 378(2):148-157. PubMed ID: 29320647 [TBL] [Abstract][Full Text] [Related]
59. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095 [TBL] [Abstract][Full Text] [Related]